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INTRODUCTION
Serratia marcescens is an aerobic Gram-negative bacillus which
can survive well in moist environments (1). S. marcescens has
been reported to cause variable infections, including respira-
tory tract, urinary tract, and wound infections and bacteremia
(1-3). S. marcescens often develops multidrug resistance and
tends to spread rapidly in the nosocomial environment (4-9),
and has been implicated in outbreaks of nosocomial infection
both in neonates and adults. S. marcescens is more likely to col-
onize the respiratory and urinary tracts of hospitalized adults
but the gastrointestinal tract in neonates (1, 10-12).
Numerous outbreaks of S. marcescens in urine have been des-
cribed (9, 13-23). Only rarely is the source of an outbreak in
urine identified, i.e., urodynamic equipment, urinometers,
or urine measuring containers (15, 16, 18). In most instances,
the presumed source of infection is healthcare workers (1, 7,
10, 13, 17). In our hospital, an increase in the number of cases
of S. marcescens was observed in urine over the past few years,
with unusual accumulations of isolates in the neurosurgical
intensive care unit (NSICU) as of March 2002. The purpose
of this study was to investigate this outbreak of S. marcescens
bacteriuria, and to report interventions. 
MATERIALS AND METHODS
Hospital setting 
Keimyung University Dongsan Medical Center is a 931-
bed tertiary care hospital in Daegu, Korea. The NSICU in-
volved in the outbreak is a 20-bed unit with two private
rooms, and is an integral part of a single ward consisting of
61 beds devoted to neurosurgical patients. Our Infection Con-
trol Unit with a full-time infection control nurse was estab-
lished in June 2000 but no Infectious Disease service was
established until March 2002. This study was conducted as
part of a quality improvement project in the NSICU in 2003.
Determination of trends of isolation of S. marcescens over
time
To determine the trends of isolation of S. marcescens over
time, we used stored computerized microbiology data dat-
ing from July 1997. Microbiologic data were analyzed by cul-
ture specimen, hospital ward, and clinical department.
Review of procedures 
We examined patient care areas and other areas of the NS-
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Three-Year Follow-up of an Outbreak of Serratia marcescens
Bacteriuria in a Neurosurgical Intensive Care Unit
We report on the investigations and interventions conducted to contain an extend-
ed outbreak of Serratia marcescens bacteriuria that lasted for years in a neurosur-
gical intensive care unit (NSICU). A case-control study was performed to identify
the risk factors for S. marcescens acquisition in urine. In case patients, urine sam-
pling for tests and central venous catheterization were performed more frequently
before the isolation of S. marcescens. Case patients were more frequently prescribed
third-generation cephalosporins. Adherence to hand antisepsis was encouraged
through in-service educational meetings and infection control measures, especially
concerning the manipulation of indwelling urinary catheters, were intensified. The
outbreak persisted despite the reinforcement of infection control measures. How-
ever, no patient has newly acquired the organism in the NSICU since December
2004. Multiple factors, including inadequate infection control practices and inappro-
priate antimicrobial usage, possibly contributed to the persistence of this S. mar-
cescens outbreak. Healthcare workers should consistently follow infection control
policies to ensure quality care.
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ICU and reviewed infection control policies and hand anti-
sepsis practices in May 2002. Additionally, we surveyed the
infection control practices of health care workers, especially
in terms of the manipulation of indwelling urinary catheters.
Case-control study
A case-control study was conducted in May 2002 to iden-
tify the risk factors for the acquisition of S. marcescens in urine.
The source population for this case-control study was defined
as all patients who had been admitted to the NSICU for ≥
72 hr from January through March 2002. A case patient was
defined as any patient in the NSICU with at least one posi-
tive culture for S. marcescens in urine. Data were collected until
the date of isolation of S. marcescens in urine. For each case,
two controls were selected from patients without isolation
of S. marcescens in urine as close as possible in time to the case.
Collection of data ended after a maximum of 7 days in the
NSICU, which was the median length of ICU stay before the
isolation of S. marcescens in the case patients.
Environmental and surveillance cultures 
Environmental cultures were obtained from potential envi-
ronmental sources, such as, sinks, counter tops, bed rails, medi-
cation carts, urinary catheters and urine bags, unused urinals,
and disinfectants in February 2003. Cultures were not obta-
ined from healthcare workers. Prospective surveillance cul-
tures were obtained from urine for all patients with indwelling
urinary catheters in the NSICU. Urine samples were taken
on the day of and 3 days after admission to the NSICU, and
thereafter weekly. Surveillance cultures were continued weekly
in the NS ward as long as urinary catheters were kept in place
after the patients were transferred to the NS ward. Routine
surveillance cultures were conducted from February through
December 2003, but not thereafter due to limited resources.
Additional surveillance cultures to measure point prevalences
were done during April 2005. Cultivation and identification
of the organism were performed according to standard pro-
cedures. Pulsed-field gel electrophoresis (PFGE) was perform-
ed for 34 S. marcescens strains isolated from April 2002 to
November 2003 as described elsewhere (23) and their frag-
mentation patterns were interpreted using previously sug-
gested criteria (24).
Statistical analysis
Univariate analysis was performed using the 2 test or the
two-tailed Fisher’s exact test (for small expected values) for
categorical variables, and using the Student’s t-test for contin-
uous variables. Multivariate analysis was performed to demon-
strate associations between individual variables and organism
acquisition. All variables that were statistically significant
by univariate analysis were analyzed using a logistic regres-
sion model. Two-tailed p values of <0.05 were considered sta-
tistically significant. All statistical analyses were performed
using SPSS software (SPSS 10.0 for Windows).
RESULTS
Ascertainment of the outbreak
From July 1997 through December 2001, a total of 1,231
S. marcescens duplicate isolates among 525 hospitalized patients
were recovered from a variety of clinical specimens. The organi-
sms were most commonly isolated from urine specimens (71.2
%) and from the NS (82.0%). Of 389 patients with S. marcescens
in urine, 340 (87.4%) were from the NS. For most of these
NS patients, acquisition of S. marcescens was identified while
they were in the NSICU (81.8%). It was evident that the out-
break was associated with urine, particularly in the NSICU.
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Fig. 1. Distribution of patients who newly acquired Serratia marcescens in urine from July 1999 through February 2005.
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The first isolate of S. marcescens from urine in the NSICU
was identified in a 51-yr old male patient transferred from
other hospital for surgical management of cerebral hemor-
rhage in July 1999. At the time of admission to the NSICU,
indwelling urinary catheter had already been placed at the
previous hospital and he revealed no signs of infection. On
hospital day 8, the organism was cultured from catheterized
urine, and found to be resistant to multiple antibiotics but
susceptible to imipenem. Thereafter S. marcescens was increas-
ingly identified in urine of patients in the NSICU and then
in the NS ward (Fig. 1). Almost all organisms showed the
similar antibiotic susceptibility pattern, although different
sets of antibiotics were used for antimicrobial susceptibility
testing during the study period. We believe that the above
transferred patient was the index case of this outbreak.
Case-control study
The demographic and clinical characteristics of 35 cases
and 70 control patients are shown in Table 1. Subarachnoid
hemorrhage was the most common diagnosis and no statis-
tical difference was found in the distribution of neurosurgi-
cal diseases between cases and controls. Urine sampling for
tests and invasive procedures were more frequently performed
in case patients. Furthermore case patients received antibiotics
for longer periods for surgical prophylaxis or empiric treat-
ment of fever of unknown etiology, and this was especially
true for third-generation cephalosporins, such as cefoperazone.
Mean length of NSICU stay before the isolation of S. marcescens
in urine was 6.9 days (median, 7; range, 3-11 days). All iso-
lates were resistant to multiple antibiotics (including cefox-
itin, cefotaxime, cefepime, gentamicin, and amikacin) and
only susceptible to imipenem. Only one isolate was suscep-
tible to ciprofloxacin. Multivariate analysis revealed that the
use of third-generation cephalosporins, urine sampling for
tests, and central venous catheterization were independent
risk factors for the acquisition of S. marcescens (Table 2). 
Procedural investigations 
Written infection control standards were in place at the
hospital, but these were not strictly followed by healthcare
workers in the NSICU. Breaks in infection control practices
were identified during the manipulation of indwelling uri-
nary catheters. Backflow of urine through a urinary catheter
was often found at the time of position changes and during
patient movements. Connection tubes were disconnected for
urine sampling for urinalysis, culture, or for the measurement
of specific gravity. The irrigation of urinary catheters was per-
formed often but not routinely. A few urinals were shared to
drain urine collected in urine bags and they were not suffi-
ciently disinfected between usages according to the current
infection control standards (25). Furthermore, hand antisep-
sis between the nursing care of individual patients was inade-
quate. However, inappropriate practices were not document-
ed at the time of catheter insertion.
Environmental and surveillance cultures 
In a patient colonized with S. marcescens in urine, environ-
mental cultures isolated S. marcescens, Staphlyococcus epidermidis,
and Acinetobacter baumannii from the surface of a urine bag.
Results of surveillance cultures are depicted with those of
clinical specimens in Fig. 1. Last point prevalence surveillance
SD, standard deviation; SAH, subarachnoid hemorrhage; ICH, intracra-
nial hemorrhage; IVH, intraventricular hemorrhage; NSICU, neurosurgi-
cal intensive care unit; ER, emergency room; NS, not significant. 
Variable Case
(n=35) (%)
Control
(n=70) (%)
p-value
Age (yr, mean±SD) 54.2±16.1 51.6±19.2 0.48
Male:female 19:16 31:39 0.33
Underlying neurosurgical 0.12
disease
SAH 18 (51.4) 21 (30.0)
ICH/IVH 7 (20.0) 11 (15.7)
Head trauma 6 (17.1) 13 (18.6)
Brain tumor 1 (2.9) 13 (18.6)
Others 3 (8.6) 12 (17.1)
Overall length of NSICU stay 16.7±10.5 8.3±5.3 <0.001
(days, mean±SD)
Length of NSICU stay before 6.9±1.9 - -
isolation of S. marcescens
(days, mean±SD)
Central venous catheterization 33 (94.3) 39 (55.7) <0.001
Other invasive procedures 22 (62.9) 29 (41.4) 0.04
Mechanical ventilation 14 (40.0) 17 (24.3) 0.10
Urinary catheterization (n=102) (n=35) (n=67)
Urinary catheter inserted at ER 33 (94.3) 44 (65.7) 0.001
Duration of urinary catheterization 7.2±2.1 8.0±5.4 0.39
(days)
Exchange of urine bag 4 (11.4) 6 (9.0) 0.73
Irrigation through urinary catheter 1 (2.9) 2 (3.0) 1.00
Urine sampling for tests 30 (85.7) 21 (31.3) 0.007
Antimicrobial therapy
Antibiotic treatment during the 33 (94.3) 61 (87.1) 0.33
first 7 days in NSICU
Use of third-generation 25/33 (75.8) 24/61 (39.3) 0.001
cephalosporins
Duration of antibiotic treatment 6.0±2.4 4.5±1.9 0.001
(day, mean±SD)
Table 1. Results of case-control study
Variable 95% CIOR p-value
Use of third-generation 5.1 1.4-17.9 0.01
cephalosporins
Urine sampling for tests 15.2 4.2-55.6 <0.001
Central venous catheterization 9.7 1.6-59.7 0.01
Table 2. Multivariate analysis of risk factors associated with ac-
quisition of Serratia marcescens in urine
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cultures in April 2005 did not grow S. marcescens from any
patient. PFGE of 34 selected strains isolated between April
2002 and November 2003 identified two distinct clones (Fig.
2). One predominant clone distributed throughout the period
above, was comprised of two closely related subtypes, and
was resistant to all antibiotics tested, except imipenem. The
other clone showed different antimicrobial susceptibility pat-
terns (Table 3). This clone had been isolated since October
2003.
Intervention and termination of the outbreak
After the procedural review and survey, adherence to hand
antisepsis was encouraged and infection control measures,
especially on the manipulation of indwelling urinary catheters
(26), were intensified through in-service educational meet-
ings for nursing staffs in the NSICU and NS ward in January
2003. Individual urinals were not recommended for economic
reasons but it was recommended that drainage valves not be
touched when draining urine. A pair of new plastic, not ster-
ile, gloves were used each time urine was drained from a urine
bag. Disconnection of connection tubes was not allowed there-
after. Urine sampling was performed only by aspiration with
a sterile needle and syringe after clamping the distal end of
the catheter and disinfection, because no sampling port was
present in available catheters. In addition, it was reinforced
against irrigation through indwelling urinary catheters. Cohort
care was employed for patients acquiring S. marcescens in urine.
For residents and attending medical staffs, a series of lectures
was given on the state of the S. marcescens outbreak in the NS-
ICU in May 2003. The outbreak lasted despite the reinforce-
ment of infection control measures, but eventually no patients
were found to have newly acquired the organism in the NS-
ICU from December 2004.
DISCUSSION
This study describes an extended outbreak of S. marcescens
in an NSICU that lasted for years. It is hypothesized that the
outbreak strain might have been introduced into our NSICU
by a neurosurgical patient who was transferred from other
hospital with a urinary catheter in place. 
Majority of postoperative neurosurgical patients are usually
admitted for intensive care with invasive monitoring (27).
Indwelling urinary catheters are often placed and regular urine
measurements, such as volume and specific gravity, are per-
formed for fluid and electrolyte management. In the case-con-
trol study, urine sampling for tests was found to be signifi-
cantly associated with the acquisition of S. marcescens by mul-
tivariate analysis. A procedural investigation revealed poor
infection control standards, especially in terms of the man-
agement of urinary catheters, which contributed to the estab-
lishment of the S. marcescens outbreak in the NSICU. Although
the exact number and intensity of direct contacts between
patients and healthcare workers were not collected, and cul-
tures were not obtained from the hands of healthcare work-
ers, we presume that after the introduction of the epidemic
strain, hand transmission probably played a major role in the
dissemination and persistence of S. marcescens. Therefore, care-
ful hand hygiene and strict adherence to basic infection con-
trol practices were the key step to terminating this outbreak.
It is noteworthy that, even when there was a high aware-
ness of existing problems and a generally high infection con-
trol level, it was exceedingly difficult to contain the outbreak.
One possible factor that contributed to its duration was pro-
Fig. 2. PFGE fingerprints of Serratia marcescens isolates. One
major clone was shared by the isolates shown in lanes 1, 2, 4, and
5 (type A) with 2 closely-related isolates (lanes 3 and 6 designat-
ed as subtypes A1 and A2, respectively). Five isolates showed a
different pattern (type B, lanes 7-11). Antimicrobial susceptibility
patterns of the isolates above are shown according to clone type
in Table 3. M, Lambda DNA size marker; C, control (E. coil O157:
H7G5244). 
M 1 2 3 4 5 6 7 8 9 10 11 C M
PPR, piperacillin; PPR/TZ, piperacillin/tazobactam; CTX, cefotaxime;
CFP, cefepime; IMI, imipenem; CIP, ciprofloxacin; GM, gentamicin;
AMK, amikacin.
Antimicrobial susceptibility pattern
PFGE
type
No. 
of iso-
lates
tested
Time 
of 
isolation PPR CTX CFP IMI CIP GM AMK
PPR/
TZ
A 27 Apr 2002- R R R R S R R R
May 2003
A1 1 Feb 2003 R R R R S R R R
A2 1 May 2003 R R R R S R R R
B 5 Oct 2003- R S R R S S R R
Nov 2003
Table 3. Antimicrobial susceptibility patterns of Serratia marce-
scens isolates for which PFGE was performed
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longed hospitalization. Some of the neurosurgical patients
stayed in the hospital for long periods for medical and sur-
gical reasons. A few of these patients were repeatedly trans-
ferred from the NSICU to the ward or vice versa, and a small
number of these patients had already acquired the organism
in urine before transfer. It is possible that new transmissions
from patients who were already colonized, but not identified,
occurred after the initial intervention during the period of
the outbreak. These patients may have been another cause of
the persistence and resurgence of the organism during inter-
vention. Prolonged hospitalization was suggested to be a risk
factor of a S. marcescens outbreak in a previous study (8).
Another factor that may have contributed to the outbreak
was the use of broad-spectrum antibiotics. Case patients receiv-
ed antibiotics more frequently and for longer periods for sur-
gical prophylaxis and for the empiric treatment of fever of
an undefined cause, especially with third-generation cepha-
losporins, such as cefoperazone. Antibiotic treatment was
likely to have predisposed these patients to the acquisition
of S. marcescens in the NSICU. It is known that third-genera-
tion cephalosporins have the ability to select S. marcescens in
the gut (28).
S. marcescens isolates from the NSICU were multidrug resis-
tant and of the antibiotics tested the predominant strain was
only susceptible to imipenem. Nosocomial outbreaks of S.
marcescens are commonly associated with multiple antimicro-
bial resistance and extended-spectrum beta-lactamase pro-
ducing isolates were recently reported from an ICU (4-6, 8).
The emergence and persistence of multidrug resistant S. mar-
cescens is clearly a cause of concern because of treatment fail-
ure. Since S. marcescens has inducible chromosomal beta-lac-
tamases (29), it is prudent to avoid the long-term use of anti-
biotics like third-generation cephalosporins, for surgical pro-
phylaxis. Nevertheless, no significant changes in antibiotic
policy or prescription pattern were observed during the course
of the outbreak (data not shown). Further efforts will be need-
ed to improve antimicrobial use.
The molecular epidemiologic study showed two different
clones. One strain, not major, was identified from a small
number of isolates tested for PFGE. S. marcescens organisms
with the same antimicrobial susceptibility pattern as this
clone were isolated rarely at irregular intervals throughout
the outbreak. However, we could not presume that these iso-
lates were identical to the minor clone. Furthermore, we were
unable to determine whether or when the new strain had been
introduced, because the same set of antibiotics was not used
in the clinical microbiology laboratory during the outbreak,
and not all S. marcescens isolates in the NSICU were collected
for PFGE during the course of this study.
This study has the following limitations. First, we did not
detect all S. marcescens colonizations or infections because sur-
veillance cultures were performed during the limited period
of the outbreak. In addition, we could not obtain cultures
from healthcare workers. Second, the relationship between
previous colonization and invasive disease was not demon-
strated for patients colonized with S. marcescens in urine. Dur-
ing the period of intervention, systemic infections caused by
this organism, such as meningitis and bacteremia, often occu-
rred in patients who had already been colonized with S. mar-
cescens in urine. However, the exact incidence of S. marcescens
infections was not estimated in the whole period and thus
could not be compared between pre- and post-intervention
period because routine surveillance had not been performed
especially in the early period of this outbreak. Nevertheless,
it can be assumed that the economic and clinical burden was
substantial during the outbreak. 
In summary, we believe that multiple factors, including
unsatisfactory hand washing practices, inadequate infection
control practices, and inappropriate antimicrobial usage, con-
tributed to the dissemination and persistence of the S. marcescens
outbreak in our NSICU. This study underscores the impor-
tance of practicing basic infection control measures in the hos-
pital. 
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